RUNX1 and neoplasm: Besides, it has been reported that lincRNA-uc002yug.2 contributes to a combination of alternative splicing (AS) factors and RUNX1 to promote ESCC progression, and this suggested that RUNX1 has a tumor-suppressing role in esophageal tumors [54].